Notoginsenoside R1 alleviates high glucose-evoked damage in RSC96 cells through down-regulation of miR-503
Notoginsenoside R1 (NGR1) is a major bioactive ingredient of Radix notoginseng that has promise in treating several diabetes-related diseases, like diabetic nephropathy and diabetic cardiomyopathy. This work is designed to explore if NGR1 has potential in treating diabetic peripheral neuropathy (DPN...
Sábháilte in:
| Príomhchruthaitheoirí: | , , |
|---|---|
| Formáid: | Alt |
| Teanga: | Béarla |
| Foilsithe / Cruthaithe: |
Taylor & Francis Group
2019-12-01
|
| Sraith: | Artificial Cells, Nanomedicine, and Biotechnology |
| Ábhair: | |
| Rochtain ar líne: | https://www.tandfonline.com/doi/10.1080/21691401.2019.1671434 |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Bí ar an gcéad duine le trácht a dhéanamh!